treprostinil sodium
ApprovedCompleted 0 watching 0 views this week🔥 Hot
82
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Pulmonary Hypertension
Conditions
Pulmonary Hypertension
Trial Timeline
Sep 1, 2006 → Jan 1, 2008
NCT ID
NCT00373360About treprostinil sodium
treprostinil sodium is a approved stage product being developed by United Therapeutics for Pulmonary Hypertension. The current trial status is completed. This product is registered under clinical trial identifier NCT00373360. Target conditions include Pulmonary Hypertension.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (4)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00643604 | Approved | Terminated |
| NCT00458042 | Approved | Terminated |
| NCT00373360 | Approved | Completed |
| NCT00058929 | Approved | Completed |
Competing Products
20 competing products in Pulmonary Hypertension